And if you had backed the TLX story as highlighted in the thread title and content of your post you would be sitting on handsome share price appreciation from $1.78 to $4.73. In the same period SPL has sunk from $1.24 to 62 cents.
The old Starpharma ‘has many irons in the fire’ and ‘optionality’ has gone well past it’s use-by date.
The stale Chairman and CEO need to go.
